Abstract
Haemophilus influenzae type b meningitis has been reported predominantly among infants who have not completed the primary immunization series, whereas infection by capsular f has been reported mostly in patients with significant underlying diseases. The present study analyses H. influenzae type b & f infection among 25 unvaccinated patients with respiratory tract infections and symptoms of meningitis by PCR. 5/7 isolates from CSF sample were capsular type b; whereas capsular type f was detected in 2/10 and 5/8 isolates from throat swab and sputum samples, respectively. Rest 13 strains were negative for both the capsular types. To conclude, in India where H. influenzae type b conjugate vaccine is not included in national immunization program, individuals with respiratory tract infections and meningitis are at a greater risk of developing infection with H. influenzae type b strains along with other capsular types and non-capsular types.
Similar content being viewed by others
References
Adams WG, Deaver KA, Cochi SL et al (1993) Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221–226
Campos J (1999) Haemophilus In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington, DC, pp 604–613
CLSI (2006) Performance standards for antimicrobial disk susceptibility tests. 25(1)
Eskola J, Peltola H, Kayhty H et al (1992) Finnish efficacy trials with Haemophilus influenzae type b vaccines. J Infect Dis 165:137–381
Falla TJ, Anderson EC, Chappell MM et al (1993) Cross-reaction of spontaneous capsule deficient Haemophilus influenzae type b mutants with type-specific antisera. Eur J Clin Microbiol Infect Dis 12:147–148
Foxwell AR, Kyd JM, Cripps AW et al (1998) Nontypable Haemophilus influenzae: Pathogenesis and prevention. Microbiol Mol Biol Rev 62:294
Kroll JS, Hopkins I, Moxon ER (1988) Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell 53:347–356
LaClaire LL, Tondella MLC, Beall DS et al (2003) Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol 41:393–396
Levine O, Wenger J, Perkins YB et al (1998) Haemophilus influenzae type b infection. Bull WHO 76:131–132
Marrs CF, Krasan GF, McCrea KW et al (2001) Haemophilus influenzae—human specific bacteria. Front Biosci 6:E41–E60
Pittman M (1931) Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 53:471–492
Tatiana B, Kathy AS, Catherine C et al (2006) Activity of LBM415 compared to those of 11 other agents against Haemophilus species. Antimicrob Agents Chemother 50:2323–2329
Turk DC (1984) The pathogenicity of Haemophilus influenzae. J Med Microbiol 18:1–16
Van Ketel RJ, De Wever B, van Alphen L (1990) Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification. J Med Microbiol 33:271–276
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahoo, S., Srivastava, S. & Ayyagari, A. Prevalence of H. influenzae type b & f among unvaccinated patients with respiratory tract infection and meningitis. World J Microbiol Biotechnol 24, 1977–1979 (2008). https://doi.org/10.1007/s11274-008-9689-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-008-9689-3